Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COHERENT
NCT04916522Phase 2Active, not recruiting
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Aug 2021
- Primary completion
- Jan 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in hypertension (HTN), sponsored by Herlev & Gentofte Hospital. Started Aug 2021; status: active, not recruiting.
02
Drugs
colchicine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04916522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04916522.